Update of the treatment of cicatricial keratoconjunctivitis;Atualização no tratamento das ceratoconjuntivites Cicatriciais

Arquivos Brasileiros de Oftalmologia

Volumn 63, Issue 1, 2000, Pages 91-96

  Gomes, José Alvaro Pereira ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Keratoconjunctivitis, cicatricial; Ocular surface

Indexed keywords

EID: 77950383089     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492000000100018     Document Type: Article

References (62)

1. Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc 1986;84:527-663.
2. Tseng SCG, Tsubota K. Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol 1997;124:825-35.
3. Whitcher JP. Clinical diagnosis of the dry eye. Int Ophthalmol Clin 1987;27:7-24.
4. Feenstra RPG, Tseng SCG. Comparison of Fluorescein and Rose Bengal Staining. Ophthalmology 1992;99:605-17.
5. Power WJ, Neves RA, Rodriguez A, Dutt JE, Foster CS. Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology 1995;102:1158-63.
6. Wolff E. The mucocutaneous junction of the lid and the distribution of the tear fluid. Trans Ophthalmol Soc UK 1946;66:291-308.
7. Tiffany JM. Composition and biophysical properties of the tear film: knowledge and uncertainty. Adv Exp Med Biol 1994;350:231-8.
8. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology 1993;100:347-51.
9. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol 1996;40:343-67.
10. Gomes JAP, Carvalho FV, Barros PS, Nishiwaki-Dantas MC, Kfouri AGD, Pinheiro RK, Peres MFP. Modelo experimental de olho seco em coelhos. Arq Bras Oftalmol 1994;57:264-9.
11. Holly FJ. Formation and stability of the tear film. Int Ophthalmol Clin 1973;13:73-7.
12. Friedland BR, Andreson DR, Forster RK. Non-lysozyme antibacterial factor in human tears. Am J Ophthalmol 1972;74:52-9.
13. Ohashi Y, Motokura M, Kinoshita Y. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci 1989;30:1879-82.
14. Ubels J, Loley K, Rismondo V. Retinol secreted by lacrimal gland. Invest Ophthalmol Vis Sci 1986;27:1261-9.
15. Haynes RJ, Tighe PJ, Dua HS. Innate defense of the eyes by antimicrobial defensin peptides. Lancet 1998;352:451-2.
16. Fox RI, Robinson CA, Curd JG. Sjögren syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
17. Tsubota K, Toda I, Yagi Y, Ogawa Y, Ono M, Yoshino K. Three different types of dry eye syndrome. Cornea 1994;13:202-9.
18. Pflugfelder S, Huang A, Feuer W, Chuchovski P, Pereira I, Tseng S. Conjunctival cytologic features of primary Sjögreńs syndrome. Ophthalmology 1990;97:985-93.
19. Inatomi T, Spurr-Michaud SJ, Tisdale AS, Gipson IK. Human corneal and conjunctival epithelia express MUC1 mucin. Invest Ophthalmol Vis Sci 1995;36:1818-27.
20. Tsubota K, Yamada M. Tear evaporation from the ocular surface. Invest Ophthalmol Vis Sci 1992;33:2942-50.
21. Lemp MA. Management of Dry-Eye patient. Int Ophthalmol Clin 1994;34:101-14.
22. Tsubota K. New Approaches In Dry Eye Management. In: Kinoshita S, Ohashi Y, eds. Current opinions in the Kyoto Cornea Club. Amsterdam: Kugler Publ 1995;27-32.
23. Toda I, Shinozaki N, Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea 1996;15:120-8.
24. Tsubota K, Satake Y, Shimazaki J. Treatment of severe dry eye. Lancet 1996;348:123.
25. American Academy of Ophthalmology: Editorial: Punctum occlusion for the dry eye. Ophthalmology 1992;99:639-40.
26. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999;83:390-5.
27. Doane MG. Interaction of eyelids and tears in corneal wetting and the dynamics of the normal human eyeblink. Am J Ophthalmol 1980;89:507-16.
28. Donnenfeld ED, Perry HD, Wallerstein A, Caronia RM, Kanellopoulos AJ, Sforza PD, D'Aversa G. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology 1999;106:72-9.
29. Shore JW, Foster CS, Westfall CT, Rubin PA. Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 1992;99:383-95.
30. Tseng SCG, Prabhasawat P, Lee S-L. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1997;124:765-74.
31. Wesley RE. Entrópio cicatricial. In: Levine MR, ed. Manual de cirurgia plástica ocular. Rio de Janeiro: Rio Medi Livros Ltda, 1994;103-9.
32. Hawes MJ. Ectrópio cicatricial. In: Levine MR, ed. Manual de cirurgia plástica ocular. Rio de Janeiro: Rio Medi Livros Ltda, 1994;117-24.
33. Boynton JR. Triquíase e Distiquíase. In: Levine MR, ed. Manual de cirurgia plástica ocular. Rio de Janeiro: Rio Medi Livros Ltda, 1994;125-34.
34. Thoft RA, Friend J. The X, Y, Z hypothesis of corneal epithelial maintenance. Invest Ophthalmol Vis Sci 1983;24:1442-3.
35. Dua HS. Stem cells of the ocular surface: scientific principles and clinical applications. Br J Ophthalmol 1995;79:968-9.
36. Dua HS, Gomes JAP, Singh A. Corneal epithelial wound healing. Br J Ophthalmol 1994;78:401-8.
37. Kenyon KR, Tseng SCG. Limbal autograft transplantation for ocular surface disorders. Ophthalmology 1989;96:709-23.
38. Tseng SCG, Chen JJY, Huang AJW, Kruse FE, Maskin SL, Tsai RJF. Classification of conjunctival surgeries for corneal diseases based on stem cell concept. Ophthalmol Clin North Am 1990;3:595-610.
39. Kwitko S, Marinho DR, Barcaro S, et al. Allograft conjunctival transplantation for bilateral ocular surface disorders. Ophthalmology 1995;102:1020-5.
40. Marinho DR, Lima ALH, Kwitko S, Kirst M, Mársico J, Roehe D. Corneal epithelial healing in rabbit eyes with partial corneal-conjunctival and conjunctival limbal deficiency. Arq Bras oftalmol 1998;61:525-38.
41. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995;14:473-84.
42. Prabhasawat P, Tseng SCG. Impression cytology study of epithelial phenotype of ocular surface reconstructed by preserved human amniotic membrane. Arch Ophthalmol 1997;115:1360-7.
43. Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 1998;116:431-41.
44. Shimazaki J, Yang H-Y, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology 1997;104:2068-76.
45. Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, Shinozaki N, Shimazaki J. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996;122:38-52.
46. Spigelman AV, Deutsch TA, Sugar A. Application of homologous fibronectin to persistent human corneal epithelial defects. Cornea 1987;6:128-30.
47. Ohji M, Mandarino L, SundarRaj N, Thoft RA. Corneal epithelial cell attachment with endogenous laminin and fibronectin. Invest Ophthalmol Vis Sci 1993;34:2487-92.
48. Gomes JAP, Gomes AKP, Figueiredo R, Marco ES, Crosta F, Dua HS, Laibson PR, Donoso LA. Effect of Sodium Hyaluronate on migration and proliferation of human corneal epithelial cells in vitro. ARVO abstracts. Invest Ophthalmol Vis Sci 1998;39:S1039.
49. Wagoner MD. Chemical injuries on the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 1997;41:275-313.
50. Tsai RJ-F, Tseng SCG. Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction. Cornea 1995;14:439-49.
51. Kenyon KR. Inflammatory mechanisms in corneal ulceration. Trans Am Ophthalmol Soc 1985;83:610-63.
52. Basu PK, Avaria M, Jankie R. Effect of hydrocortisone on the mobilisation of leucocytes in corneal wounds. Br J Ophthalmol 1981;65:694-8.
53. Davis AR, Ali QH, Aclimandos WA, Hunter PA. Topical steroid use in the treatment of ocular alkali burns. Br J Ophthalmol 1997;81:732-4.
54. Gross J, Azizkhan RG, Biswas C. Inhibition of tumor growth, vascularization and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 1981;78:1176-80.
55. Mindel J, Mishima S. Imunosuppresive drugs in immune and inflammatory ocular disease. Surv Ophthalmol 1991;35:369-85.
56. Uusitalo RJ, Mahlberg K, Krootila K, Ruusuvaara P. Systemic cyclosporin treatment for high-risk corneal transplantation. Ocul Immunol Inflam 1996;4:15-24.
57. Holland EJ, Olsen TW, Ketcham JM, Florine C, Krachmer JH, Purcell JJ, Lam S, Tessler HH, Sugar J. Topical Cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993;12:413-9.
58. Garcia-Hirschfeld J, Lopez-Briones L, Belmonte C. Neurotrophic influences on corneal epithelial cells. Exp Eye Res 1994;59:597-605.
59. Araki-Sasaki K. The mechanism of neurotrophic keratitis. In: Kinoshita S Ohashi Y, eds. Current opinions in the Kyoto cornea club. Amsterdam: Kugler Publications, 1996;69-78.
60. Reid TW, Tran P, Nishida T, Murphy CJ. The stimulation of rabbit corneal epithelial cell migration in culture by substance P, is synergistic with insulin and IGF-1. ARVO abstracts. Invest Opthalmol Vis Sci 1999;40:S99.
61. Lambiase A, Bonini S, Micera A, Rama P, Bonini S, Aloe L. Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestations of inflammatory diseases. Invest Opthalmol Vis Sci 1998;39:1272-5.
62. Lambiase A, Rama P, Ghinelli E, Pasqualetti R, Aloe L, Bonini S. Nerve growth factor promotes corneal healing: structural, biochemical and molecular analysis on rat and human cornea. ARVO abstracts. ARVO abstracts. Invest Opthalmol Vis Sci 1999;40:S92.